Ribas A, Milhem MM, Hoimes CJ, Amin A, et al. Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced Melanoma. Clin Cancer Res 2025 Jul 25. doi: 10.1158/1078-0432.CCR-25-0987.
PMID: 40711475